Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Dec. 2025,
Medibank Pvt paidA$19 Mil more to buy back shares than it received from issuing new shares.
It spentA$22 Mil paying down its debt.
It paidA$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spentA$285 Mil paying cash dividends to shareholders.
It receivedA$0 Mil on other financial activities.
In all, Medibank PvtspentA$326 Mil on financial activities for the
six
months ended in Dec. 2025.
Medibank Pvt (ASX:MPL) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Medibank Pvt's issuance of stock for the
six
months ended in Dec. 2025 was A$0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Medibank Pvt's repurchase of stock for the
six
months ended in Dec. 2025 was A$-19 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Medibank Pvt's net issuance of debt for the
six
months ended in Dec. 2025 was A$-22 Mil.
Medibank Pvt spentA$22 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Medibank Pvt's net issuance of preferred for the
six
months ended in Dec. 2025 was A$0 Mil.
Medibank Pvt paidA$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Medibank Pvt's cash flow for dividends for the
six
months ended in Dec. 2025 was A$-285 Mil.
Medibank Pvt spentA$285 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Medibank Pvt's other financing for the
six
months ended in Dec. 2025 was A$0 Mil.
Medibank Pvt receivedA$0 Mil on other financial activities.
Medibank Pvt Cash Flow from Financing Related Terms
Medibank Pvt Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Medibank Pvt's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Medibank Pvt's Cash from Financing for the fiscal year that ended in Jun. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-567 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of A$-567 Mil mean?
Medibank Pvt (ASX:MPL) has a Cash Flow from Financing of A$-567 Mil as of Dec. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Medibank Pvt and its competitors.
Is Medibank Pvt's Cash Flow from Financing too high?
Medibank Pvt's current Cash Flow from Financing is A$-567 Mil. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's Cash Flow from Financing compare to FNF and AXS?
Medibank Pvt's Cash Flow from Financing of A$-567 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for an Insurance company?
A good Cash Flow from Financing depends on the Insurance industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Medibank Pvt and its competitors. Medibank Pvt's current Cash Flow from Financing is A$-567 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.39, compared to a current price of A$5.00 — trading 13.9% above its estimated fair value. The current Cash Flow from Financing is A$-567 Mil. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current Cash Flow from Financing is A$-567 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.00 is trading 13.9% above its estimated GF Value™ of A$4.39.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
Cash Flow from Financing: A$-567 Mil
GF Value™: A$4.39 vs. price of A$5.00 (13.9% above fair value)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score
Get the complete analysis for ASX:MPL
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
